Iranex bought Bio Serae in 2008 and projected its new entity will increase revenue from the present €83m to €120m by 2015.
Bio Serae offerings include cactus extract Cacti-Nea while the CNI stable includes Fibregum and Equacia.
News, Analysis & Insights on Nutrition, Supplements, and Health
Iranex bought Bio Serae in 2008 and projected its new entity will increase revenue from the present €83m to €120m by 2015.
Bio Serae offerings include cactus extract Cacti-Nea while the CNI stable includes Fibregum and Equacia.